Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dextromethorphan for treatment-resistant obsessive-compulsive disorder
IRCT20120520009801N6Phase 2Completed
- Sponsor
- Mashhad University of Medical Sciences
- Start
- Aug 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of dextromethorphan in refractory obsessive-compulsive disorder (TR-OCD), sponsored by Mashhad University of Medical Sciences. Started Aug 2022; status: completed.
02
Drugs
dextromethorphan
03
Conditions
refractory obsessive-compulsive disorder (TR-OCD)
Beyond the preview
Go deeper on IRCT20120520009801N6.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20120520009801N6.